{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:29Z","timestamp":1790085569889,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119898","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:30:14Z","timestamp":1788291014000},"page":"119898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A luciferase-based high-throughput three-dimensional tumor spheroid model identifies a renieramycin T derivative with anti-cancer stem cell activity in non-small cell lung cancer"],"prefix":"10.1016","volume":"203","author":[{"given":"Parinya","family":"Samart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supasorn","family":"Chanthateyanonth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napachai","family":"Rodboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitit","family":"Charoenvitayavorakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yokoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pithi","family":"Chanvorachote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surapol","family":"Issaragrisil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1639-4935","authenticated-orcid":false,"given":"Sudjit","family":"Luanpitpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","article-title":"Non-small-cell lung cancer","volume":"10","author":"Hendriks","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"17","key":"10.1016\/j.biopha.2026.119898_bib2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa2503001","article-title":"Overall survival with amivantamab-lazertinib in EGFR-mutated advanced NSCLC","volume":"393","author":"Yang","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.biopha.2026.119898_bib3","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1056\/NEJMoa2503704","article-title":"Zongertinib in previously treated HER2-mutant non-small-cell lung cancer","volume":"392","author":"Heymach","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119898_bib5","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3390\/cancers15102855","article-title":"Novel targets, novel treatments: the changing landscape of non-small cell lung cancer","volume":"15","author":"de Jong","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer stem cells: landscape, challenges and emerging therapeutic innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2026.119898_bib7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4252\/wjsc.v15.i6.576","article-title":"Clinical relevance of stem cells in lung cancer","volume":"15","author":"Romeo","year":"2023","journal-title":"World J. Stem Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12672-025-02102-4","article-title":"Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations","volume":"16","author":"Obisi","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lungcan.2012.02.006","article-title":"Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy","volume":"77","author":"Shien","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.biopha.2026.119898_bib10","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2147\/CMAR.S551828","article-title":"Combined detection of tumor stem cell markers CD133 and OCT4 in early non-small cell lung cancer screening and prognostic evaluation","volume":"17","author":"Guan","year":"2025","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.biopha.2026.119898_bib11","doi-asserted-by":"crossref","DOI":"10.4252\/wjsc.v17.i9.106381","article-title":"Expression of cancer stem cell markers and their prognostic significance in stage IIIA non-small cell lung cancer","volume":"17","author":"Lin","year":"2025","journal-title":"World J. Stem Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/s41598-022-05176-0","article-title":"Triple-negative expression (ALDH1A1-\/CD133-\/mutant p53-) cases in lung adenocarcinoma had a good prognosis","volume":"12","author":"Yamashita","year":"2022","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.biopha.2026.119898_bib13","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.7150\/jca.20172","article-title":"Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer","volume":"8","author":"Huang","year":"2017","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s12672-025-03190-y","article-title":"Therapeutic potential of natural compounds in targeting cancer stem cells: a promising approach for cancer treatment","volume":"16","author":"Debnath","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/bit.26845","article-title":"3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs","volume":"116","author":"Nunes","year":"2019","journal-title":"Biotechnol. Bioeng."},{"issue":"18","key":"10.1016\/j.biopha.2026.119898_bib16","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.3390\/cancers13184610","article-title":"3D cancer models: depicting cellular crosstalk within the tumour microenvironment","volume":"13","author":"Franchi-Mendes","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-025-02281-2","article-title":"3D tumor cultures for drug resistance and screening development in clinical applications","volume":"24","author":"Peng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2026.119898_bib18","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00432-016-2198-0","article-title":"Evaluation of assays for drug efficacy in a three-dimensional model of the lung","volume":"142","author":"Huber","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119898_bib19","first-page":"69","article-title":"3D cell culture systems modeling tumor growth determinants in cancer target discovery","author":"Thoma","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12672-025-02132-y","article-title":"Spheroid morphology of lung cancer cell lines correlates with oncological profiles","volume":"16","author":"Oishi","year":"2025","journal-title":"Discov. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119898_bib21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/md22080370","article-title":"A new renieramycin T right-half analog as a small molecule degrader of STAT3","volume":"22","author":"Phookphan","year":"2024","journal-title":"Mar. Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2026.119898_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/md21120627","article-title":"Simplified synthesis of renieramycin T derivatives to target cancer stem cells via \u03b2-catenin proteasomal degradation in human lung cancer","volume":"21","author":"Ei","year":"2023","journal-title":"Mar. Drugs"},{"issue":"6","key":"10.1016\/j.biopha.2026.119898_bib23","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.3390\/ijms24065345","article-title":"Novel synthetic derivative of renieramycin T right-half analog induces apoptosis and inhibits cancer stem cells via targeting the Akt signal in lung cancer cells","volume":"24","author":"Petsri","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-26668-9","article-title":"QSAR machine learning-guided discovery of renieramycin right-half derivatives with cytotoxic activity against NSCLC cells","volume":"15","author":"Putra","year":"2025","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119898_bib25","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.21873\/invivo.13292","article-title":"Renieramycin T derivative DH_22 induces p53-dependent apoptosis in lung cancer cells","volume":"37","author":"Anggraeni","year":"2023","journal-title":"Vivo"},{"issue":"W1","key":"10.1016\/j.biopha.2026.119898_bib26","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119898_bib27","first-page":"baq020","article-title":"GeneCards Version 3: the human gene integrator","volume":"2010","author":"Safran","year":"2010","journal-title":"Database (Oxf. )"},{"issue":"D1","key":"10.1016\/j.biopha.2026.119898_bib28","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib29","article-title":"The Gene Ontology knowledgebase in 2023","volume":"224","year":"2023","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"Goto S. KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.biopha.2026.119898_bib31","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119898_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS. One"},{"issue":"D1","key":"10.1016\/j.biopha.2026.119898_bib33","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.biopha.2026.119898_bib34","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.biopha.2026.119898_bib35","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.biopha.2026.119898_bib36","article-title":"BCSCdb: a database of biomarkers of cancer stem cells","volume":"2022","author":"Firdous","year":"2022","journal-title":"Database (Oxf. )"},{"issue":"22","key":"10.1016\/j.biopha.2026.119898_bib37","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/onc.2015.351","article-title":"SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma","volume":"35","author":"Luanpitpong","year":"2016","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.biopha.2026.119898_bib38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41419-019-1898-1","article-title":"Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer","volume":"10","author":"Herreros-Pomares","year":"2019","journal-title":"Cell. Death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2026.119898_bib39","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.3892\/or.2015.4163","article-title":"Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.119898_bib40","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3892\/mmr.2016.5524","article-title":"Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2","volume":"14","author":"Zhao","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2026.119898_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127348","article-title":"A reliable parameter to standardize the scoring of stem cell spheres","volume":"10","author":"Zhou","year":"2015","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.biopha.2026.119898_bib42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4103\/jcrt.JCRT_213_18","article-title":"Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: a clinicopathological association","volume":"16","author":"Upadhyay","year":"2020","journal-title":"J. Cancer Res. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.119898_bib43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell. Death Differ."},{"issue":"11","key":"10.1016\/j.biopha.2026.119898_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014062","article-title":"Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties","volume":"5","author":"Leung","year":"2010","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.biopha.2026.119898_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100168","article-title":"Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS. One"},{"key":"10.1016\/j.biopha.2026.119898_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2025.102028","article-title":"The clinicopathologic and prognostic value of CD44 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"81","author":"Alaei","year":"2025","journal-title":"Mol. Cell. Probes"},{"issue":"23","key":"10.1016\/j.biopha.2026.119898_bib47","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","article-title":"Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling","volume":"70","author":"Sullivan","year":"2010","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119898_bib48","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1158\/0008-5472.CAN-06-3557","article-title":"Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells","volume":"67","author":"Ho","year":"2007","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.biopha.2026.119898_bib49","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.3390\/ijms232113306","article-title":"Comparison of EMT-related and multi-drug resistant gene expression, extracellular matrix production, and drug sensitivity in NSCLC spheroids generated by scaffold-free and scaffold-based methods","volume":"23","author":"Qi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119898_bib50","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/2472555217697434","article-title":"3D models of the NCI60 cell lines for screening oncology compounds","volume":"22","author":"Selby","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.biopha.2026.119898_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100220","article-title":"Leveraging network pharmacology for drug discovery: integrative approaches and emerging insights","volume":"27","author":"Li","year":"2025","journal-title":"Med. Drug. Discov."},{"issue":"12","key":"10.1016\/j.biopha.2026.119898_bib52","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s12032-025-03086-5","article-title":"BS. Harnessing GSK-3\u03b2 inhibition for lung cancer therapy: emerging opportunities and challenges","volume":"42","author":"Hassanein","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2026.119898_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174546","article-title":"Poly (ADP-ribose) polymerase (PARP) inhibition in cancer: potential impact in cancer stem cells and therapeutic implications","volume":"911","author":"Rizvi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2014.05.004","article-title":"Identification of stem-like cells in non-small cell lung cancer cells with specific peptides","volume":"351","author":"Wang","year":"2014","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.biopha.2026.119898_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.93","article-title":"Non-small cell lung cancer stem\/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity","volume":"3","author":"Akunuru","year":"2012","journal-title":"Cell. Death Dis."},{"issue":"38","key":"10.1016\/j.biopha.2026.119898_bib56","doi-asserted-by":"crossref","first-page":"16281","DOI":"10.1073\/pnas.0905653106","article-title":"Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment","volume":"106","author":"Bertolini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2026.119898_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003077","article-title":"Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties","volume":"3","author":"Levina","year":"2008","journal-title":"PLoS. One"},{"issue":"29","key":"10.1016\/j.biopha.2026.119898_bib58","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1016\/j.tetlet.2009.05.014","article-title":"Chemistry of renieramycins. Part 7: renieramycins T and U, novel renieramycin\u2013ecteinascidin hybrid marine natural products from Thai sponge Xestospongia sp","volume":"50","author":"Daikuhara","year":"2009","journal-title":"Tetrahedron Lett."},{"issue":"5","key":"10.1016\/j.biopha.2026.119898_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3390\/md17050301","article-title":"Renieramycin T induces lung cancer cell apoptosis by targeting Mcl-1 degradation: a new insight in the mechanism of action","volume":"17","author":"Petsri","year":"2019","journal-title":"Mar. Drugs"},{"issue":"37","key":"10.1016\/j.biopha.2026.119898_bib60","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1016\/j.tet.2014.07.012","article-title":"Preparation of renieramycin left-half model compounds","volume":"70","author":"Nakai","year":"2014","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/md17010003","article-title":"Asymmetric synthesis and cytotoxicity evaluation of right-half models of antitumor renieramycin marine natural products","volume":"17","author":"Matsubara","year":"2018","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2026.119898_bib62","first-page":"5627","article-title":"CD44 promotes cell proliferation in non-small cell lung cancer","volume":"15","author":"Hu","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.biopha.2026.119898_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell. Stem Cell."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112288","article-title":"Aryl hydrocarbon receptor mediates Jak2\/STAT3 signaling for non-small cell lung cancer stem cell maintenance","volume":"396","author":"Xiong","year":"2020","journal-title":"Exp. Cell. Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119898_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189461","article-title":"STAT3 axis in cancer and cancer stem cells: from oncogenesis to targeted therapies","volume":"1880","author":"Godugu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2026.119898_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcancer.2017.06.001","article-title":"The JAK\/STAT3 axis: a comprehensive drug target for solid malignancies","volume":"45","author":"Huynh","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119898_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056284","article-title":"New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.biopha.2026.119898_bib68","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/cells9061388","article-title":"Glycogen synthase kinase 3\u03b2 in cancer biology and treatment","volume":"9","author":"Domoto","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119898_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.621050","article-title":"Glycogen synthase kinase-3 beta expression correlates with worse overall survival in non-small cell lung cancer\u2014a clinicopathological series","volume":"11","author":"Alves","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2026.119898_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1195426","article-title":"The multifaceted roles of matrix metalloproteinases in lung cancer","volume":"13","author":"Wei","year":"2023","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119898_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116140","article-title":"Targeting CDK2 for cancer therapy","volume":"44","author":"Knudsen","year":"2025","journal-title":"Cell. Rep."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2026.119898_bib72","article-title":"The dual role of cyclin D1: unraveling its tumor-promoting mechanisms and opportunities for therapeutics","volume":"333","author":"Taheri","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib73","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1038\/s41467-025-60326-y","article-title":"Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation in non-small-cell-lung-cancer patients","volume":"16","author":"Tomin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119898_bib74","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.csbj.2023.07.034","article-title":"GAPDH: a common housekeeping gene with an oncogenic role in pan-cancer","volume":"21","author":"Wang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"10.1016\/j.biopha.2026.119898_bib75","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119898_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e13829","article-title":"Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer","volume":"9","author":"Surina","year":"2023","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.biopha.2026.119898_bib77","article-title":"Clinical relevance of patient-derived organoid of surgically resected lung cancer as an in vitro model for biomarker and drug testing","volume":"4","author":"Koga","year":"2023","journal-title":"JTO Clin. Res. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:00:58Z","timestamp":1790082058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"alternative-id":["S0753332226009340"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119898","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A luciferase-based high-throughput three-dimensional tumor spheroid model identifies a renieramycin T derivative with anti-cancer stem cell activity in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119898"}}